enVVeno Medical NVNO
NASDAQ NVNO
$11.11 -0.51 (-4.35%)
As of: Sep 9, 2026 · 2:32 PM EDT

enVVeno Medical (NVNO) Price to Sales (2018 - 2019)

enVVeno Medical (NVNO) posted Price to Sales of 706.77 for Q1 2019, up 55.92% on a QoQ basis from 453.3 in Q4 2018.

Analysis

enVVeno Medical (NVNO) Price to Sales (2018 - 2019) Analysis & Trends

enVVeno Medical has reported Price to Sales for 2 years, with the latest figure at 706.77 in Q1 2019.

  • On a quarterly basis, Price to Sales changed N/A year-over-year to 706.77 in Q1 2019; TTM through Dec 2019 was 315.66, a 326.46% increase from a year earlier, with the FY2019 full-year figure at 315.66, up 326.46% from the prior year.
  • Price to Sales was 706.77 for Q1 2019 at enVVeno Medical, up from 453.3 in the prior quarter.
  • The five-year high for Price to Sales was 753.73 in Q3 2018, with the low at 350.04 in Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.63 Bn 178.03 Bn 7.27 Bn
2 Intuitive Surgical 124.13 Bn 118.91 Bn 1.96 Bn
3 Medtronic 118.51 Bn 109.69 Bn 6.34 Bn
4 Stryker 106.53 Bn 103.06 Bn 4.50 Bn
5 Boston Scientific 66.52 Bn 65.98 Bn 3.85 Bn
6 Edwards Lifesciences 49.57 Bn 45.32 Bn 1.35 Bn
7 Alcon 34.00 Bn 32.55 Bn 1.68 Bn
8 Dexcom 32.03 Bn 30.08 Bn 830.00 Mn
9 Steris 21.12 Bn 20.64 Bn 684.20 Mn
10 enVVeno Medical 7.46 Mn 7.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 706.77
Dec 31, 2018 453.30
Sep 30, 2018 753.73
Jun 30, 2018 350.04